When.com Web Search

  1. Ad

    related to: stiff neck from computer use and cancer risk free trial offer astrazeneca

Search results

  1. Results From The WOW.Com Content Network
  2. Merck-AstraZeneca breast cancer drug reduces risk of ... - AOL

    www.aol.com/finance/merck-astrazeneca-breast...

    Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows ... free survival is having the cancer actually come back as an advanced breast ...

  3. Pfizer wins $107.5 million from AstraZeneca in US cancer drug ...

    www.aol.com/news/pfizer-wins-107-5-million...

    AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent ...

  4. Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer ...

    www.aol.com/finance/pfizer-wins-107-5m-verdict...

    A Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc (NYSE:PFE) $107.5 million in damages, concluding that AstraZeneca’s blockbuster lung cancer drug ...

  5. Computer-induced medical problems - Wikipedia

    en.wikipedia.org/wiki/Computer-induced_medical...

    Computer-induced health problems can be an umbrella term for the various problems a computer user can develop from extended and incorrect computer use. A computer user may experience many physical health problems from using computers extensively over a prolonged period in an inefficient manner. The computer user may have poor etiquette when ...

  6. AstraZeneca's Imfinzi plus chemoradiotherapy fail main goal ...

    www.aol.com/news/astrazenecas-imfinzi-plus...

    The trial did not achieve statistical significance for progression-free survival versus CRT alone, it said, adding th AstraZeneca's Imfinzi plus chemoradiotherapy fail main goal of late stage ...

  7. AstraZeneca Imfinzi plus chemotherapy gets US nod for ... - AOL

    www.aol.com/news/astrazeneca-imfinzi-plus...

    Endometrial cancer ranks as the fourth most prevalent cancer among women in the U.S. In 2022, it affected more than 66,000 patients and was responsible for nearly 12,000 fatalities.

  8. AstraZeneca's breast cancer drug combination fails in late ...

    www.aol.com/news/astrazenecas-breast-cancer-drug...

    The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients with inoperable or metastatic triple-negative breast cancer versus the older and ...

  9. AstraZeneca's (AZN) Imfinzi Misses Goal in Cervical Cancer Study

    www.aol.com/news/astrazenecas-azn-imfinzi-misses...

    AstraZeneca's (AZN) blockbuster drug Imfinzi fails to achieve progression-free survival endpoint with statistical significance in cervical cancer patients during a late-stage study.